About Harrow
Harrow is a company based in Nashville (United States) founded in 2012. It operates as a Direct-to-Consumer (D2C), and Professional Services. The company has 382 employees as of December 31, 2024. Harrow has completed 1 acquisition, including Melt Pharmaceuticals. Harrow offers products and services including Ophthalmic Medications, Compounding Business, and Branded Therapies. Harrow operates in a competitive market with competitors including Cardinal Health, Moxie, Orbital Therapeutics, CG Life and W2O Group, among others.
- Headquarter Nashville, United States
- Employees 382 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Harrow, Inc.
-
Annual Revenue
$199.61 M53.32as on Dec 31, 2024
-
Net Profit
$-17.48 M28.39as on Dec 31, 2024
-
EBITDA
$22.89 M77.17as on Dec 31, 2024
-
Latest Funding Round
$10.7 M (USD), Post-IPO
May 01, 2021
- Investors
-
Employee Count
382
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Harrow
Harrow is a publicly listed company on the NASDAQ with ticker symbol HROW in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Harrow
Harrow offers a comprehensive portfolio of products and services, including Ophthalmic Medications, Compounding Business, and Branded Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Essential medications for eyecare are provided by Harrow.
Specialized compounding solutions for eyecare are offered here.
Proven branded therapies for vision are delivered by Harrow.
Unlock access to complete
Unlock access to complete
Funding Insights of Harrow
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $10.7M
-
First Round
First Round
(01 May 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Post-IPO - Harrow | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Harrow
Harrow has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Riley Financial. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mergers, acquisitions, capital raising, and strategic advisory services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Harrow
Harrow has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Melt Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical solutions are developed by Melt Pharmaceuticals in the US.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Harrow
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Harrow Comparisons
Competitors of Harrow
Harrow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Moxie, Orbital Therapeutics, CG Life and W2O Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple healthcare products and services are provided to organizations.
|
|
| domain | founded_year | HQ Location |
Medical spa marketing services are provided by Moxie.
|
|
| domain | founded_year | HQ Location |
Distributor of RNA medicines
|
|
| domain | founded_year | HQ Location |
Healthcare marketing services are provided by CG Life.
|
|
| domain | founded_year | HQ Location |
Marketing communications services are delivered to businesses worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Harrow
Frequently Asked Questions about Harrow
When was Harrow founded?
Harrow was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Where is Harrow located?
Harrow is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
How many employees does Harrow have?
As of Dec 31, 2024, the latest employee count at Harrow is 382.
What is the annual revenue of Harrow?
Annual revenue of Harrow is $199.61M as on Dec 31, 2024.
What does Harrow do?
Harrow, Inc. is dedicated to redefining eyecare through a comprehensive portfolio of ophthalmic pharmaceuticals. Solutions are developed to ensure safety, efficacy, and affordability for eyecare professionals and patients. The company operates in the rapidly growing ophthalmic market, offering essential medications, specialized compounding services, and branded therapies. Innovation and accessibility are prioritized to enhance patient outcomes and drive industry impact. Growth, operational excellence, and corporate responsibility are emphasized to shape the future of vision care. Access to high-quality, affordable treatments is ensured for the broader healthcare community.
Who are the top competitors of Harrow?
Harrow's top competitors include Cardinal Health, Moxie and The Cigna Group.
What products or services does Harrow offer?
Harrow offers Ophthalmic Medications, Compounding Business, and Branded Therapies.
Is Harrow publicly traded?
Yes, Harrow is publicly traded on NASDAQ under the ticker symbol HROW.
How many acquisitions has Harrow made?
Harrow has made 1 acquisition, including Melt Pharmaceuticals.
Who are Harrow's investors?
Harrow has 1 investor. Key investors include B. Riley Financial.
What is Harrow's ticker symbol?
The ticker symbol of Harrow is HROW on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.